SCHEMBL9020129

SCHEMBL9020129

CN1C2CCC1CC(c1nsc3ccccc13)C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.47
DRD3 P35462 3/20 0.47
DRD4 P21917 2/20 0.47
GRM2 Q14416 1/20 0.47
HTR1A P08908 3/20 0.40
HTR2A P28223 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
HIF1A Q16665 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
MAPT P10636 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
CHRNA1 P02708 1/20 0.37
CHRNG P07510 1/20 0.37
CHRM5 P08912 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8230683 0.99 DRD2 (0.46) DRD2DRD3DRD4GRM2HTR1A
SCHEMBL1840347 0.79 DRD2 (0.58) DRD2DRD3DRD4GRM2HTR1A
Hydrochloric Acid SCHEMBL1836699 0.78 DRD2 (0.57) DRD2DRD3DRD4GRM2HTR1A
Bromide SCHEMBL10365464 0.78 DRD2 (0.57) DRD2DRD3DRD4GRM2HTR1A
SCHEMBL1177928 0.76 SLC6A2 (0.52) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL8207212 0.76 HTR2A (0.41) DRD2DRD3DRD4GRM2HTR1A
Hydrochloric Acid SCHEMBL1178256 0.75 SLC6A2 (0.51) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL8206871 0.73 HTR2A (0.43) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL2204018 0.73 DRD2 (0.46) DRD2DRD3DRD4GRM2HTR1A
SCHEMBL10991961 0.73 DRD2 (0.52) DRD2DRD3DRD4GRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5234931-A Anxiolytic agents; antdepressants; schizophrenia; drug abuse; medical diagnosis HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-08-10 US claimed
EP-0498331-B1 N-(aryloxyalkyl)heteroaryl-8-azabicyclo(3.2.1)octanes, intermediates and a process for the preparation thereof and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1996-05-22 EP disclosed
US-5334599-A Heteroaryl-8-azabicyclo[3,2,1]octanes as antipsychotic agents, 5-HT3 receptor antagonists and inhibitors of the reuptake of serotonin HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-02 US disclosed
US-5234931-A Anxiolytic agents; antdepressants; schizophrenia; drug abuse; medical diagnosis HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-08-10 US disclosed
EP-0498331-A1 N-(aryloxyalkyl)heteroaryl-8-azabicyclo(3.2.1)octanes, intermediates and a process for the preparation thereof and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-08-12 EP disclosed